476 results on '"Mitrani, Raul"'
Search Results
2. Electrogram morphology recurrence guided catheter ablation for repeat ablation of persistent atrial fibrillation
3. Mechanistic Insights From Trials of Atrial Fibrillation Ablation: Charting a Course for the Future
4. Contemporary outcomes of acute ischemic stroke in atrial fibrillation patients on anticoagulation
5. A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial
6. Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients The CCTRN SENECA Trial
7. Abstract 17924: Machine Learning Analysis of the Atrial ECG in Patients With Persistent Atrial Fibrillation Predicts Long-Term Outcomes
8. Abstract 17011: Correlation of Surface Atrial ECG Dominant Frequency to Intracardiac Atrial Electrogram Dominant Frequency
9. Abstract 16967: Effect of Catheter Ablation of Persistent Atrial Fibrillation on Surface Atrial ECG Dominant Frequency
10. Abstract 16784: Utility of 4D Flow MRI to Quantify Improvement of Left Atrial Hemodynamics Following Cardioversion for Atrial Fibrillation
11. Abstract 15869: Antiarrhythmic Effects of Mesenchymal Stromal Cells in a Post-Infarct Swine Model of Ventricular Tachycardia
12. Abstract 15640: Long Term Event-Free Survival in Patients With Ischemic and Non-Ischemic Cardiomyopathy up to Thirteen Years Following Cell-Based Therapy: Results From the Hyperion Observational Cohort
13. Abstract 12823: As Anticoagulation Use Increases, Embolic Events Downtrend in Atrial Fibrillation Hospitalizations
14. Electrogram Morphology Recurrence for Mapping Persistent Atrial Fibrillation: Initial vs Redo Catheter Ablation
15. Long-term cardiac surveillance and outcomes of COVID-19 patients
16. Early trends in leadless pacemaker implantation: Evaluating nationwide in-hospital outcomes
17. Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials
18. Demographic representation in clinical trials for cell-based therapy
19. The Management of Electrical Storm in a Patient with Non-Ischemic Cardiomyopathy
20. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
21. Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy
22. In-hospital Outcomes of Ischemic Stroke in Atrial Fibrillation Patients on Anticoagulation: A Retrospective Analysis
23. Ablation strategies for the management of symptomatic Brugada syndrome: A systematic review
24. Ventricular Tachycardia and Fibrillation in Patients with Structural Heart Disease
25. Hospital Admissions for Chest Pain Associated with Cocaine Use in the United States
26. Differences Between Access to Follow-Up Care and Inappropriate Shocks Based on Insurance Status of Implantable Cardioverter Defibrillator Recipients
27. Abstract 17454: The Effect of Catheter Ablation on Coronary Sinus Cycle Length in Persistent Atrial Fibrillation
28. Abstract 16896: Electrogram Morphology Recurrence to Characterize Drivers of Persistent Atrial Fibrillation: Findings at Initial versus Redo Catheter Ablation
29. Abstract 14080: A Phase II Randomized, Double-blind, Controlled Trial of Combined Mesenchymal Stromal Cells and C-kit+ Cardiac Progenitor Cells in Ischemic Heart Failure: The CCTRN CONCERT-HF Trial
30. LB-456089-1 PRE-ABLATION WEIGHT LOSS AS A PREDICTOR OF ATRIAL FIBRILLATION ABLATION OUTCOME IN THE LIRAGLUTIDE EFFECT ON ATRIAL FIBRILLATION (LEAF) STUDY
31. Gender, Race, and Health Insurance Status in Patients Undergoing Catheter Ablation for Atrial Fibrillation
32. Ten advances defining sudden cardiac death
33. Comparison of electrogram characteristics in persistent atrial fibrillation.
34. ELECTROGRAM MORPHOLOGY RECURRENCE IN RESPONDERS VERSUS NONRESPONDERS TO PULMONARY VEIN ISOLATION FOR PERSISTENT ATRIAL FIBRILLATION
35. COMPARING THE ATRIAL ELECTROCARDIOGRAM IN ATRIAL FIBRILLATION IN ANTERIOR VERSUS POSTERIOR CHEST LEADS
36. ATRIAL ECG DYNAMICS IN ATRIAL FIBRILLATION
37. New-onset versus prior history of atrial fibrillation: Outcomes from the AFFIRM trial
38. Management of Conduction Disturbances Post‐ TAVR
39. Comparison of Electrogram Characteristics in Persistent Atrial Fibrillation
40. Optimal Blood Pressure in Patients With Atrial Fibrillation (from the AFFIRM Trial)
41. Transient variations of transthoracic impedance as a predictor of heart failure and death in patients with implanted defibrillators
42. Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapy
43. Outcomes in Atrial Fibrillation Patients With and Without Left Ventricular Hypertrophy When Treated With a Lenient Rate-Control or Rhythm-Control Strategy
44. Impact of Nontraditional Antiarrhythmic Drugs on Sudden Cardiac Death
45. Contributors
46. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure)
47. Cardiac Troponin Testing as a Component of Return to Play Cardiac Screening in Young Competitive Athletes Following SARS‐CoV‐2 Infection
48. ST-T Wave Abnormality in Lead aVR and Reclassification of Cardiovascular Risk (from the National Health and Nutrition Examination Survey-III)
49. QRS Duration on Electrocardiography and Cardiovascular Mortality (from the National Health and Nutrition Examination Survey—III)
50. Comparison of Rate Versus Rhythm Control in Patients With Atrial Fibrillation and a Pacemaker
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.